title: Pharmacologic and clinicopharmacologic properties of SDZ ENA 713, a centrally selective acetylcholinesterase inhibitor.
authors.affiliation: Preclinical Research CNS Department, Sandoz Pharma Ltd., Basle, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Enz
authors.forename: H
authors.initials: H
authors.lastname: Boddeke
authors.forename: J
authors.initials: J
authors.lastname: Gray
authors.forename: R
authors.initials: R
authors.lastname: Spiegel
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism; D000818:Animals; D002219:Carbamates / Q000378:metabolism / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D048448:Phenylcarbamates; D010830:Physostigmine / Q000378:metabolism / Q000627:therapeutic use; D010919:Placebos; D051381:Rats; D000068836:Rivastigmine
chemical_list: D002219:Carbamates; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D010919:Placebos; D010830:Physostigmine; D000068836:Rivastigmine